Asadi, Fatemeh, Ashkuh, Mohammad Sadegh, Asadi, Mohammad Reza (2021). Whole exome sequencing identified a de novo variant in the IDS gene in a patient with mild form of the Mucopolysaccharidosis type II. , 24(2), 35-40.
Fatemeh Asadi; Mohammad Sadegh Ashkuh; Mohammad Reza Asadi. "Whole exome sequencing identified a de novo variant in the IDS gene in a patient with mild form of the Mucopolysaccharidosis type II". , 24, 2, 2021, 35-40.
Asadi, Fatemeh, Ashkuh, Mohammad Sadegh, Asadi, Mohammad Reza (2021). 'Whole exome sequencing identified a de novo variant in the IDS gene in a patient with mild form of the Mucopolysaccharidosis type II', , 24(2), pp. 35-40.
Asadi, Fatemeh, Ashkuh, Mohammad Sadegh, Asadi, Mohammad Reza Whole exome sequencing identified a de novo variant in the IDS gene in a patient with mild form of the Mucopolysaccharidosis type II. , 2021; 24(2): 35-40.

Whole exome sequencing identified a de novo variant in the IDS gene in a patient with mild form of the Mucopolysaccharidosis type II

Pathobiology Reserach
Article 4, Volume 24, Issue 2, 2021, Pages 35-40    PDF (263.6 K)
Document Type: Case Report
Authors
Fatemeh Asadi* 1; Mohammad Sadegh Ashkuh2; Mohammad Reza Asadi3
1Department of Molecular Genetics, Marvdasht Branch, Islamic Azad University, Marvdasht, Iran; Tel.: (+98-71) 43311172; Fax: (+98-71) 43112201
2Department of Neurology, Shiraz University of Medical Science, Shiraz, Iran.
3Department of Speech Therapy, School of Rehabilitation, Arak University of Medical Sciences, Arak, Iran
Abstract
Mucopolysaccharidosis (MSII) is described as a metabolic disorder resulting from an enzymatic failure causing from mutations in IDS gene, MPSII is divided into two forms; mild and severe. The first form does not affect intelligence and patients show no neurologic involvements, usually survive for the fourth decade of life. In patients with severe form, death mostly occurs due to neurologic involvement during the second decade of life. We reported a case, a 31-year-old patient, clinically suspicious to MPS II which was primarily diagnosed by the presence of the increased levels of dermatan and heparan sulfate in urine and I2S deficiency in plasma. Whole exome sequencing was utilized to detect the disease-causing variant in our patient. A de novo mutation (c.253G>A, (p.A85T) in exon 3 of the IDS gene was identified, which probably can describe the mild form of MPSII and clinical manifestations observed in the patient.
Keywords
Mucopolysaccharidosis; IDS gene; de novo; Mutation; Exome sequencing
References
Statistics
Article View: 121
PDF Download: 61
Statistics
Number of Journals45
Number of Issues2,171
Number of Articles24,674
Article View24,444,853
PDF Download17,554,035